Aug 4, 2022 by Patrick BafumaThese 3 Companies Are Taking on MonkeypoxA vaccine maker, a therapeutics company, and a medical lab could suit a variety of investor risk profiles.
Aug 3, 2022 by Patrick BafumaFamed "Big Short" Investor Loves This Multibillion-Dollar Company -- Should You?Will Bristol-Myers Squibbs' pipeline and newly approved drugs overcome its expiring patents?
Jun 19, 2022 by Patrick Bafuma, George Budwell, and Taylor CarmichaelBuy the Dip on These 3 Healthcare StocksHere's why our roundtable likes Vir Biotechnology, OrthoPediatrics, and Vertex Pharmaceuticals.
May 2, 2022 by Patrick BafumaNovartis Is Looking for Deals. Are These 3 Biotechs on Its List?CEO Vas Narasimhan is seeking acquisitions under $2 billion.
Apr 29, 2022 by Patrick BafumaThese Charts Explain Why I'm Holding This Healthcare CompanyTransplants are in high demand; this company is making the process of getting one smoother.
Apr 28, 2022 by Patrick Bafuma2 Healthcare Stocks That Could Go ParabolicThese two companies are poised for a comeback.
Apr 28, 2022 by Patrick BafumaThis Chart Is Why I'm Not Worried About Guardant HealthThe leading innovator in the liquid biopsy space has huge addressable markets ahead of it.
Apr 27, 2022 by Patrick BafumaWhy I'm Over the Moon for This Healthcare Stock -- In One ChartThis company helps keep patients at home with dialysis treatments.
Apr 26, 2022 by Patrick BafumaThings Just Got Worse for BiogenThe company just withdrew its Aduhelm regulatory submission in the EU.
Apr 20, 2022 by Patrick BafumaMissed Intuitive Surgical? Buy This Stock InsteadMuch as Intuitive Surgical redefined the surgical field, this company is updating how abnormal heart rhythms are diagnosed.
Apr 20, 2022 by Patrick BafumaThis Chart Is Why I'm Holding This Stock for the Next DecadeThis biotech's products are a must-have for scientists.
Apr 15, 2022 by Patrick Bafuma2 Medtech Stocks You Can Buy and Hold for the Next DecadeThese two companies are leading the charge for improved patient outcomes.
Apr 11, 2022 by Patrick Bafuma2 Under-the-Radar Biotech Stocks to Buy in 2022Both companies have catalysts for explosive growth this year.
Apr 8, 2022 by Patrick Bafuma2 Top Biotech Stocks to Buy in AprilThese shares are down significantly from all-time highs, but the businesses have plenty of room for growth.
Apr 7, 2022 by Patrick Bafuma2 Top Biotech Stocks to Buy for the Long HaulRepligen and Exact Sciences have a proven track record with significant opportunities for continued growth.
Apr 6, 2022 by Patrick Bafuma3 Healthcare Stocks to Buy and Hold for the Next 10 YearsThese companies have a history of creating shareholder value -- and still have plenty of room for growth.
Apr 6, 2022 by Patrick Bafuma2 Biotechs With Recent FDA Approvals to Hold for the Next DecadeWith trials aimed at increasing addressable markets in the coming years, Legend and Immunocore could reward investors.
Apr 2, 2022 by Patrick BafumaCustomers Love These 3 Healthcare CompaniesNet Promoter Scores can provide insights into customer satisfaction, and possibly lead to market-beating returns.
Dec 18, 2021 by Patrick Bafuma3 Last-Minute Healthcare Stocking StuffersHere are three stocks sure to pique the interest of that special someone.
Nov 24, 2021 by Patrick Bafuma and Alex Carchidi10x Genomics Stock: Bull vs. BearAfter a hot start, the stock has recently lagged the market. Is now a good time to buy?
